Associate Prof, Dr Chen Yeng has a track record of around 100 publications in renowned peer-reviewed scientific journals (Journal of Hematology & Oncology, Current Gene Therapy, Biosensors & Bioelectronics, PlosOne, BMC, etc) including publications in books and patents. She is an Editorial Board Member and Reviewer of a number of international journals (including BioMed Central Journals, Phytomedicine, Biosensors & Bioelectronics, Scientific Reports, Oral Disease etc). Chen Yeng's research of interest spans around Proteomics and Immunoproteomics studies in various Infectious and Non- Infectious Diseases. She is currently pursuing to expand her interest of study on Cancer Genetics and Aptamer based therapies.
She mainly works on biomarker discovery and designing/developing biosensors to screen and validate the biomarkers of different diseases. For biomarkers discovery, different -omics platforms (proteomics, metabolomic and genomics) are used. From discovery, large-scale screening follows using a self-developed biosensor to validate the data. Besides, she collaborates on research in Herbalism including Herbology, Herbal Medicine, Phytomedicine, Phytotherapy, and Phytopharmacology.
Short Biography
Associate Prof, Dr Chen Yeng has a track record of around 100 publications in renowned peer-reviewed scientific journals (Journal of Hematology & Oncology, Current Gene Therapy, Biosensors & Bioelectronics, PlosOne, BMC, etc) including publications in books and patents. She is an Editorial Board Member and Reviewer of a number of international journals (including BioMed Central Journals, Phytomedicine, Biosensors & Bioelectronics, Scientific Reports, Oral Disease etc). Chen Yeng's research of interest spans around Proteomics and Immunoproteomics studies in various Infectious and Non- Infectious Diseases. She is currently pursuing to expand her interest of study on Cancer Genetics and Aptamer based therapies.
She mainly works on biomarker discovery and designing/developing biosensors to screen and validate the biomarkers of different diseases. For biomarkers discovery, different -omics platforms (proteomics, metabolomic and genomics) are used. From discovery, large-scale screening follows using a self-developed biosensor to validate the data. Besides, she collaborates on research in Herbalism including Herbology, Herbal Medicine, Phytomedicine, Phytotherapy, and Phytopharmacology.